FAP and neoplasm: A preclinical study demonstrated rapid accumulation and long retention of lutetium-177 (177Lu)-radiolabeled FAP-2286 in FAP-positive tumors resulting in significant tumor growth suppression, with minimal uptake in normal organs [16].